| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Feng-Ming Spring Kong | Q85174881 |
| Michael MacManus | Q86572574 | ||
| P2093 | author name string | X Allen Li | |
| Ursula Nestle | |||
| Sarah Everitt | |||
| Tanja Schimek-Jasch | |||
| P2860 | cites work | A pilot study of [18F]fluorodeoxyglucose positron emission tomography scans during and after radiation-based therapy in patients with non small-cell lung cancer. | Q53472506 |
| Radiation pneumonitis: local dose versus [18F]-fluorodeoxyglucose uptake response in irradiated lung. | Q53491275 | ||
| First-line erlotinib and bevacizumab in patients with locally advanced and/or metastatic non-small-cell lung cancer: a phase II study including molecular imaging. | Q54656705 | ||
| The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer | Q57272532 | ||
| Detection of brain metastases from small cell lung cancer | Q57407207 | ||
| Effects of radiotherapy planning with a dedicated combined PET-CT-simulator of patients with non-small cell lung cancer on dose limiting normal tissues and radiation dose-escalation: A planning study | Q57618377 | ||
| Time trends in the maximal uptake of FDG on PET scan during thoracic radiotherapy. A prospective study in locally advanced non-small cell lung cancer (NSCLC) patients | Q57661139 | ||
| Lung Cancer | Q57758728 | ||
| Abscopal Effects after Conventional and Stereotactic Lung Irradiation of Non–Small-Cell Lung Cancer | Q57758819 | ||
| Association Between Pulmonary Uptake of Fluorodeoxyglucose Detected by Positron Emission Tomography Scanning After Radiation Therapy for Non–Small-Cell Lung Cancer and Radiation Pneumonitis | Q57758859 | ||
| Early mortality after radical radiotherapy for non-small-cell lung cancer: comparison of PET-staged and conventionally staged cohorts treated at a large tertiary referral center | Q57758990 | ||
| Ablative therapies for lung metastases: a need to acknowledge the efficacy and toxicity of stereotactic ablative body radiotherapy | Q59587265 | ||
| A radiographic and tomographic imaging system integrated into a medical linear accelerator for localization of bone and soft-tissue targets | Q61903143 | ||
| Myocardial perfusion damage after mediastinal irradiation for Hodgkin's disease: a thallium-201 single photon emission tomography study | Q67593691 | ||
| Acute radiation-induced pulmonary damage: a clinical study on the response to fractionated radiation therapy | Q69752388 | ||
| The mediastinum in non-small cell lung cancer: CT-surgical correlation | Q71007657 | ||
| Recovery of overall and local lung function loss 18 months after irradiation for malignant lymphoma | Q71059751 | ||
| Evaluation of oxygenation status during fractionated radiotherapy in human nonsmall cell lung cancers using [F-18]fluoromisonidazole positron emission tomography | Q72054584 | ||
| Lung cancer: evaluation with MR imaging during and after irradiation | Q72256998 | ||
| Radiation-induced pulmonary injury: symptomatic versus subclinical endpoints | Q73802904 | ||
| Perfusion characteristics of radiation-injured lung on Gd-DTPA-enhanced dynamic magnetic resonance imaging | Q74512751 | ||
| Fluorine-18 deoxyglucose positron emission tomography for the detection of bone metastases in patients with non-small cell lung cancer | Q77181931 | ||
| 18F-deoxyglucose positron emission tomography (FDG-PET) for the planning of radiotherapy in lung cancer: high impact in patients with atelectasis | Q77811636 | ||
| ¹⁸F-FDG PET-CT during chemo-radiotherapy in patients with non-small cell lung cancer: the early metabolic response correlates with the delivered radiation dose | Q95355127 | ||
| Radiomics: extracting more information from medical images using advanced feature analysis | Q23760733 | ||
| The potential for an enhanced role for MRI in radiation-therapy treatment planning | Q27691311 | ||
| New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada | Q27860904 | ||
| New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) | Q28131668 | ||
| The use of fused PET/CT images for patient selection and radical radiotherapy target volume definition in patients with non-small cell lung cancer: results of a prospective study with mature survival data | Q30609124 | ||
| Selective mediastinal node irradiation based on FDG-PET scan data in patients with non-small-cell lung cancer: a prospective clinical study | Q30993299 | ||
| Prospective assessment of radiotherapy-associated cardiac toxicity in breast cancer patients: analysis of data 3 to 6 years after treatment | Q31123683 | ||
| Associations of Radiomic Data Extracted from Static and Respiratory-Gated CT Scans with Disease Recurrence in Lung Cancer Patients Treated with SBRT | Q31152462 | ||
| Cone beam CT evaluation of patient set-up accuracy as a QA tool | Q33365076 | ||
| An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage. | Q33590850 | ||
| High rate of detection of unsuspected distant metastases by pet in apparent stage III non-small-cell lung cancer: implications for radical radiation therapy. | Q34266149 | ||
| Radial probe EBUS versus CT-guided needle biopsy for evaluation of peripheral pulmonary lesions: an economic analysis | Q34353015 | ||
| CT-based radiomic signature predicts distant metastasis in lung adenocarcinoma | Q34466023 | ||
| Radiomic feature clusters and prognostic signatures specific for Lung and Head & Neck cancer | Q34488635 | ||
| The effect of tumor volume and its change on survival in stage III non-small cell lung cancer treated with definitive concurrent chemoradiotherapy | Q34720945 | ||
| Geographic miss of lung tumours due to respiratory motion: a comparison of 3D vs 4D PET/CT defined target volumes | Q34780782 | ||
| From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors | Q34978457 | ||
| Lung texture in serial thoracic computed tomography scans: correlation of radiomics-based features with radiation therapy dose and radiation pneumonitis development. | Q35251578 | ||
| Changes in functional lung regions during the course of radiation therapy and their potential impact on lung dosimetry for non-small cell lung cancer | Q35455018 | ||
| Semiquantification and classification of local pulmonary function by V/Q single photon emission computed tomography in patients with non-small cell lung cancer: potential indication for radiotherapy planning | Q35956399 | ||
| Computed tomographic features predictive of local recurrence in patients with early stage lung cancer treated with stereotactic body radiation therapy | Q35990998 | ||
| Metabolic response assessment with (18)F-FDG PET/CT: inter-method comparison and prognostic significance for patients with non-small cell lung cancer | Q36024114 | ||
| F-18 fluorodeoxyglucose positron emission tomography staging in radical radiotherapy candidates with nonsmall cell lung carcinoma: powerful correlation with survival and high impact on treatment | Q43732874 | ||
| Observer variation in contouring gross tumor volume in patients with poorly defined non-small-cell lung tumors on CT: the impact of 18FDG-hybrid PET fusion | Q43796430 | ||
| 18F-FDG PET in characterizing adrenal lesions detected on CT or MRI. | Q43830069 | ||
| PET imaging of tumor hypoxia using 18F-fluoroazomycin arabinoside in stage III-IV non-small cell lung cancer patients. | Q44310429 | ||
| The impact of time between staging PET/CT and definitive chemo-radiation on target volumes and survival in patients with non-small cell lung cancer | Q44361015 | ||
| Positron emission tomography is superior to computed tomography scanning for response-assessment after radical radiotherapy or chemoradiotherapy in patients with non-small-cell lung cancer | Q44381576 | ||
| High-resolution imaging of pulmonary ventilation and perfusion with 68Ga-VQ respiratory gated (4-D) PET/CT. | Q44518809 | ||
| The performance of( 18)F-fluorodeoxyglucose positron emission tomography in small solitary pulmonary nodules. | Q44919921 | ||
| Early FDG-PET imaging after radical radiotherapy for non-small-cell lung cancer: inflammatory changes in normal tissues correlate with tumor response and do not confound therapeutic response evaluation | Q45068481 | ||
| Metabolic (FDG-PET) response after radical radiotherapy/chemoradiotherapy for non-small cell lung cancer correlates with patterns of failure | Q46539778 | ||
| Tumor regression and positional changes in non-small cell lung cancer during radical radiotherapy | Q47594919 | ||
| Regional differences in lung radiosensitivity after radiotherapy for non-small-cell lung cancer | Q47917216 | ||
| Cone-beam computed tomography for lung cancer - validation with CT and monitoring tumour response during chemo-radiation therapy | Q48253278 | ||
| Interfractional variations in patient setup and anatomic change assessed by daily computed tomography | Q48256364 | ||
| Flat-panel cone-beam computed tomography for image-guided radiation therapy | Q48540443 | ||
| Dosimetric Impact of Using a Virtual Couch Shift for Online Correction of Setup Errors for Brain Patients on an Integrated High-Field Magnetic Resonance Imaging Linear Accelerator. | Q48598415 | ||
| Survival prediction of non-small cell lung cancer patients using radiomics analyses of cone-beam CT images. | Q48604409 | ||
| Population and patient-specific target margins for 4D adaptive radiotherapy to account for intra- and inter-fraction variation in lung tumour position | Q48922235 | ||
| Clinical application of image-guided radiotherapy, IGRT (on the Varian OBI platform). | Q50745293 | ||
| Influence of experience and qualification on PET-based target volume delineation. When there is no expert--ask your colleague. | Q51103075 | ||
| Serial megavoltage CT imaging during external beam radiotherapy for non-small-cell lung cancer: observations on tumor regression during treatment. | Q51407884 | ||
| Simultaneous positron emission tomography (PET) assessment of metabolism with ¹⁸F-fluoro-2-deoxy-d-glucose (FDG), proliferation with ¹⁸F-fluoro-thymidine (FLT), and hypoxia with ¹⁸fluoro-misonidazole (F-miso) before and during radiotherapy in patien | Q51533883 | ||
| F-18-FDG-PET confined radiotherapy of locally advanced NSCLC with concomitant chemotherapy: results of the PET-PLAN pilot trial. | Q51581499 | ||
| Ga-68 MAA Perfusion 4D-PET/CT Scanning Allows for Functional Lung Avoidance Using Conformal Radiation Therapy Planning. | Q51668099 | ||
| Portal imaging to assess set-up errors, tumor motion and tumor shrinkage during conformal radiotherapy of non-small cell lung cancer. | Q51688515 | ||
| Accuracy of 18F-FDG PET-CT in triaging lung cancer patients with suspected brain metastases for MRI. | Q52150653 | ||
| CT texture analysis can help differentiate between malignant and benign lymph nodes in the mediastinum in patients suspected for lung cancer. | Q52991685 | ||
| Quantitative assessment of global lung inflammation following radiation therapy using FDG PET/CT: a pilot study. | Q53088229 | ||
| Stage migration in planning PET/CT scans in patients due to receive radiotherapy for non-small-cell lung cancer. | Q53088675 | ||
| High-risk CT features for detection of local recurrence after stereotactic ablative radiotherapy for lung cancer. | Q53098154 | ||
| Imaging of hypoxia with 18F-FAZA PET in patients with locally advanced non-small cell lung cancer treated with definitive chemoradiotherapy. | Q53101024 | ||
| Comparison of EORTC criteria and PERCIST for PET/CT response evaluation of patients with metastatic colorectal cancer treated with irinotecan and cetuximab. | Q53113694 | ||
| The PET-boost randomised phase II dose-escalation trial in non-small cell lung cancer. | Q53167191 | ||
| Residual ¹⁸F-FDG-PET uptake 12 weeks after stereotactic ablative radiotherapy for stage I non-small-cell lung cancer predicts local control. | Q53171205 | ||
| Preoperative staging of lung cancer with PET/CT: cost-effectiveness evaluation alongside a randomized controlled trial. | Q53251677 | ||
| Using fluorodeoxyglucose positron emission tomography to assess tumor volume during radiotherapy for non-small-cell lung cancer and its potential impact on adaptive dose escalation and normal tissue sparing | Q36054772 | ||
| Computed tomography guided management of interfractional patient variation | Q36177205 | ||
| LungTech, an EORTC Phase II trial of stereotactic body radiotherapy for centrally located lung tumours: a clinical perspective | Q36235727 | ||
| Positron-emission tomography and assessment of cancer therapy | Q36384310 | ||
| Lungtech, a phase II EORTC trial of SBRT for centrally located lung tumours - a clinical physics perspective | Q36485777 | ||
| Systematic Endobronchial Ultrasound-guided Mediastinal Staging Versus Positron Emission Tomography for Comprehensive Mediastinal Staging in NSCLC Before Radical Radiotherapy of Non-small Cell Lung Cancer: A Pilot Study | Q36653508 | ||
| [18F]-FDG uptake dose-response correlates with radiation pneumonitis in lung cancer patients | Q36766549 | ||
| Radiation pneumonitis: correlation of toxicity with pulmonary metabolic radiation response | Q36968113 | ||
| The Role of Lung Lobes in Radiation Pneumonitis and Radiation-Induced Inflammation in the Lung: A Retrospective Study | Q36969240 | ||
| Exclusion of elective nodal irradiation is associated with minimal elective nodal failure in non-small cell lung cancer | Q37119006 | ||
| Use of PET and PET/CT for radiation therapy planning: IAEA expert report 2006-2007. | Q37356029 | ||
| What is the best way to contour lung tumors on PET scans? Multiobserver validation of a gradient-based method using a NSCLC digital PET phantom | Q37424511 | ||
| Natural growth and disease progression of non-small cell lung cancer evaluated with 18F-fluorodeoxyglucose PET/CT. | Q37600536 | ||
| Timing and intensity of changes in FDG uptake with symptomatic esophagitis during radiotherapy or chemo-radiotherapy | Q37717566 | ||
| European Organisation for Research and Treatment of Cancer recommendations for planning and delivery of high-dose, high-precision radiotherapy for lung cancer | Q37809675 | ||
| MRI of the lung: state of the art. | Q37995538 | ||
| Hypoxia imaging using Positron Emission Tomography in non-small cell lung cancer: implications for radiotherapy | Q38007647 | ||
| Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study | Q38409259 | ||
| PET-based dose painting in non-small cell lung cancer: Comparing uniform dose escalation with boosting hypoxic and metabolically active sub-volumes | Q38413306 | ||
| PET/CT imaging for target volume delineation in curative intent radiotherapy of non-small cell lung cancer: IAEA consensus report 2014. | Q38419113 | ||
| Improved inter-observer agreement of an expert review panel in an oncology treatment trial--Insights from a structured interventional process | Q38567364 | ||
| Classification and evaluation strategies of auto-segmentation approaches for PET: Report of AAPM task group No. 211. | Q38766127 | ||
| A systematic review of outcomes following stereotactic ablative radiotherapy in the treatment of early-stage primary lung cancer | Q38790915 | ||
| Usefulness of four dimensional (4D) PET/CT imaging in the evaluation of thoracic lesions and in radiotherapy planning: Review of the literature | Q38822488 | ||
| Ventilation/Perfusion Positron Emission Tomography--Based Assessment of Radiation Injury to Lung | Q38974148 | ||
| Outcomes of Modestly Hypofractionated Radiation for Lung Tumors: Pre- and Mid-Treatment Positron Emission Tomography-Computed Tomography Metrics as Prognostic Factors | Q39029324 | ||
| Stereotactic Ablative Body Radiotherapy for the Treatment of Spinal Oligometastases. | Q39150755 | ||
| Motion management strategies and technical issues associated with stereotactic body radiotherapy of thoracic and upper abdominal tumors: A review from NRG oncology | Q39186802 | ||
| Differential (18)F-FDG and (18)F-FLT Uptake on Serial PET/CT Imaging Before and During Definitive Chemoradiation for Non-Small Cell Lung Cancer | Q39191502 | ||
| Early Assessment of Treatment Responses During Radiation Therapy for Lung Cancer Using Quantitative Analysis of Daily Computed Tomography. | Q40219054 | ||
| Impact of 4D-(18)FDG-PET/CT imaging on target volume delineation in SBRT patients with central versus peripheral lung tumors. Multi-reader comparative study | Q40791837 | ||
| Early treatment volume reduction rate as a prognostic factor in patients treated with chemoradiotherapy for limited stage small cell lung cancer | Q41335077 | ||
| External validation of a prognostic CT-based radiomic signature in oropharyngeal squamous cell carcinoma | Q41492192 | ||
| Metabolic Tumor Volume on PET Reduced More than Gross Tumor Volume on CT during Radiotherapy in Patients with Non-Small Cell Lung Cancer Treated with 3DCRT or SBRT. | Q42167591 | ||
| Mobilization of viable tumor cells into the circulation during radiation therapy. | Q42237728 | ||
| SPECT analysis of cardiac perfusion changes after whole-breast/chest wall radiation therapy with or without active breathing coordinator: results of a randomized phase 3 trial | Q42455396 | ||
| High rates of tumor growth and disease progression detected on serial pretreatment fluorodeoxyglucose-positron emission tomography/computed tomography scans in radical radiotherapy candidates with nonsmall cell lung cancer | Q42972813 | ||
| Methods for staging non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines | Q43413826 | ||
| Utility of positron emission tomography compared with mediastinoscopy for delineating involved lymph nodes in stage III lung cancer: insights for radiotherapy planning from a surgical cohort | Q43503185 | ||
| P433 | issue | 6 | |
| P921 | main subject | adaptive radiation therapy | Q180507 |
| P304 | page(s) | 670-688 | |
| P577 | publication date | 2017-12-01 | |
| P1433 | published in | Translational lung cancer research | Q26842616 |
| P1476 | title | Anatomic, functional and molecular imaging in lung cancer precision radiation therapy: treatment response assessment and radiation therapy personalization | |
| P478 | volume | 6 |
| Q61455998 | Evaluation of planar bioluminescence imaging and microPET/CT for therapy monitoring in a mouse model of pigmented metastatic melanoma |
| Q88427802 | Impact of Computer-Aided CT and PET Analysis on Non-invasive T Staging in Patients with Lung Cancer and Atelectasis |
| Q89524776 | LungRegNet: An unsupervised deformable image registration method for 4D-CT lung |
| Q47128344 | Potential future consideration for imaging and blood-based biomarkers for precision medicine in lung cancer |
| Q94410990 | Preface |
| Q64094553 | Pulmonary delivery of transferrin receptors targeting peptide surface-functionalized liposomes augments the chemotherapeutic effect of quercetin in lung cancer therapy |
Search more.